M5V Stock Chart & Stats
€1.00
-€0.05(-3.72%)
At close: 4:00 PM EDT
€1.00
-€0.05(-3.72%)
Day’s Range― - ―
52-Week Range€0.73 - €4.79
Previous CloseN/A
Volume0.00
Average Volume (3M)150.00
Market Cap
€24.81M
Enterprise Value€484.76
Total Cash (Recent Filing)€101.05M
Total Debt (Recent Filing)€132.17M
Price to Earnings (P/E)―
Beta0.58
Next Earnings
Nov 11, 2026EPS Estimate
-0.94Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.83
Shares Outstanding32,032,654
10 Day Avg. Volume0
30 Day Avg. Volume150
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)0.14
Price to Sales (P/S)0.25
P/FCF Ratio-3.45
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€1.68Price Target Upside68.50% Upside
Rating ConsensusHold
Number of Analyst Covering4
EPS Forecast (FY)0.5
Revenue Forecast (FY)€361.96M
Bulls Say, Bears Say
Bulls Say
Manageable LeverageRelatively low leverage gives eHealth financial flexibility while it works through operating volatility. A sizable equity base and stable total debt can support restructuring, investment in enrollment capabilities, and liquidity management without the immediate burden of heavy debt service.
Structural Cost Reduction And AutomationLarge recurring cost reductions can improve the company’s operating model if maintained beyond the current restructuring period. Lower expense intensity, reinforced by AI-enabled screening and back-office automation, could increase efficiency and help restore cash generation as enrollment activity recovers.
Lifetime Advisory And Cross-Selling PotentialA lifetime advisory model broadens eHealth’s relationship with enrolled members beyond the initial transaction. Higher cross-selling, retention, and lifetime value could diversify commission revenue, improve monetization of acquired customers, and make the platform more valuable to consumers and carriers over time.
Bears Say
Severe Revenue And Enrollment ContractionThe sharp decline in revenue and Medicare submissions indicates a material contraction in the company’s core distribution activity. Because commissions depend on enrollment volume, sustained weakness would pressure scale, reduce carrier-driven revenue, and make recovery dependent on successful future marketing and enrollment execution.
Persistently Weak Cash ConversionRepeated negative operating and free cash flow shows that improved accounting profitability has not translated into internally generated cash. Persistent weak conversion can consume liquidity, constrain investment in growth initiatives, and increase reliance on existing balance-sheet resources while the business model is being reset.
Medicare Profit And Tail Revenue CompressionMedicare remains the company’s central market, so major gross-profit and tail-revenue declines weaken the economics of its most important segment. Lower recurring commission contribution reduces earnings durability and leaves future profitability more exposed to enrollment volume and plan-mix recovery.
Ehealth News
M5V FAQ
What was Ehealth’s price range in the past 12 months?
Ehealth lowest stock price was €0.73 and its highest was €4.79 in the past 12 months.
What is Ehealth’s market cap?
Ehealth’s market cap is €24.81M.
When is Ehealth’s upcoming earnings report date?
Ehealth’s upcoming earnings report date is Nov 11, 2026 which is in 47 days.
How were Ehealth’s earnings last quarter?
Ehealth released its earnings results on Aug 04, 2026. The company reported -€0.946 earnings per share for the quarter, missing the consensus estimate of -€0.718 by -€0.228.
Is Ehealth overvalued?
According to Wall Street analysts Ehealth’s price is currently Undervalued.
Does Ehealth pay dividends?
Ehealth does not currently pay dividends.
What is Ehealth’s EPS estimate?
Ehealth’s EPS estimate is -0.94.
How many shares outstanding does Ehealth have?
Ehealth has 32,032,654 shares outstanding.
What happened to Ehealth’s price movement after its last earnings report?
Ehealth reported an EPS of -€0.946 in its last earnings report, missing expectations of -€0.718. Following the earnings report the stock price went up 0.847%.
Which hedge fund is a major shareholder of Ehealth?
Currently, no hedge funds are holding shares in DE:M5V
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Ehealth
eHealth, Inc. operates a digital health insurance marketplace within the United States, dedicated to engaging consumers, educating them, and simplifying the health insurance enrollment process. Its operations are categorized into two main divisions: Medicare offerings, and policies tailored for individuals, families, and small enterprises. Through its sophisticated digital platforms, eHealth organizes and presents comprehensive health insurance data, empowering individuals, families, and small businesses to thoroughly research, analyze, compare, and ultimately acquire a diverse range of health insurance plans. This online marketplace grants consumers access to a vast array of insurance products from various health carriers. These include options such as Medicare Advantage, Medicare Supplement, Part D prescription drug plans, individual and family coverage, small business policies, and various ancillary health insurance products. The company promotes these health plans across its proprietary web platforms, such as eHealth.com and Medicare.com, alongside engaging with a network of strategic marketing partners. Beyond its primary marketplace functions, eHealth, Inc. also licenses its unique e-commerce technology to health insurance providers, facilitating their online marketing and distribution efforts. Furthermore, it provides services including digital sponsorship, advertising placements, and lead generation. Founded in 1997, eHealth, Inc. maintains its headquarters in Santa Clara, California.
M5V Company Deck
M5V Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a balanced mix of strong operational progress and short-term financial headwinds. Positive developments include the launch of the lifetime advisory model with encouraging early cross-sell results, meaningful cost reductions, substantial quarterly cash flow improvement, AI-driven efficiency gains, and maintained guidance with a roadmap to return to growth in 2027. Offsetting these positives are steep year-over-year declines in Q2 revenue (down 45%), compressed Medicare gross profit (down ~68.6%), deeper GAAP and adjusted EBITDA losses, lower tail revenue, and higher per-member customer care costs. Management expects additional near-term revenue headwinds due to planned marketing reductions before re-allocating spend into Q4. Overall, the call signals progress on restructuring and cash-flow improvement but continued short-term operational and revenue challenges.View all DE:M5V earnings summariesM5V Stock 12 Month Forecast
Average Price Target
€1.68
▲(68.50% Upside)